000			03424nam a22002895i 4500
001			402622
003			ES-MaUEC
005			20240528105915.0
007			cr nn 008mamaa
008			230810s2023 si | o |||| 0|eng d
020			_a9789819914210
024	7		_a10.1007/978-981-99-1421-0 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC254-282 _b2023 EB
245	0	0	_aTumor Therapeutic Regimens and Comprehensive Evaluation : _bA comprehensive evaluation of malignant tumor treatments for clinicians _cedited by Qiu Li, Xiao-Shi Zhang
250			_a1st ed. 2023
264		1	_aSingapore _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aMedicine in General Introduction -- Medicine in Brain Tumors -- Medicine in Head and Neck Tumors -- Medicine in Nasopharyngeal Cancer -- Medicine in Lung Cancer -- Medicine in Pleural Mesothelioma -- Medicine in Thymoma -- Medicine in Breast Cancer -- Medicine in Esophageal Cancer -- Medicine in Gastric Cancer -- Medicine in Liver Cancer -- Medicine in Biliary Tumors -- Medicine in Pancreatic Cancer -- Medicine in Pancreatic Neuroendocrine Tumors -- Medicine in Colorectal Cancer -- Medicine in Anal Canal Cancer -- Medicine in Gastrointestinal Stromal Tumor -- Medicine in Gynecological Tumors -- Medicine in Urinary System Tumors -- Medicine in Male Reproductive System Tumors -- Medicine in Melanoma -- Medicine in Osteosarcoma -- Medicine in Soft Tissue Sarcoma -- Medicine in Malignant Lymphoma -- Medicine in Multiple Myeloma -- Medicine in Unknown Primary Malignant Tumors.
520			_aThis book starts from the clinical reality, take practicality as the purpose, closely integrate clinical work, including important clinical therapeutic regimens for various cancer, and describes the new developments in treatment of common malignant tumors. At the same time, in combination with improved version of the ASCO value framework, systematic and standardized comparisons and in-depth evaluations of therapeutic regimens were made to promote the standardization of medical treatment decisions for malignant tumors. Compared with the traditional evaluation method of malignant tumor therapeutic regimens, the evaluation method of this book has outstanding advantages. First, the evaluation indicators are comprehensive and diverse. The evaluation includes multiple indicators such as clinical benefits, adverse reactions, additional benefits, and costs, and includes more effective evaluation indicators to comprehensively evaluate the treatment plan. Second, the evaluation indicators are converted into numerical values, and different indicators are effectively quantified to make the result evaluation easier and more objective. This book systematically and comprehensively reflects the highest level of diagnosis and treatment of common oncology from a new perspective. It has great clinical guidance value and will be a valuable reference book for clinicians, medical students, graduate students and related researchers.
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-99-1421-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
988			_aSpringer_Medicine_2023
999			_c402622 _d402622